Melissa Shu Feng Ng

Melissa Shu Feng Ng

Auto-generated profile, based on publicly available information

Melissa Shu Feng Ng

Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in Nature
Verified
Journal Article
Closed access
PDF file
NCNicoletta Caronni
Nicoletta Caronni
FTFederica La Terza
Federica La Terza
FVFrancesco M. Vittoria
Francesco M. Vittoria
GBGiulia Barbiera
Giulia Barbiera
LMLuca Mezzanzanica
Luca Mezzanzanica
RORenato Ostuni
Renato Ostuni

12 January 2024 in Science
Verified
Journal Article
Closed access
MNMelissa S. F. Ng
Melissa S. F. Ng
IKImmanuel Kwok
Immanuel Kwok
LTLeonard Tan
Leonard Tan
CSChangming Shi
Changming Shi
DCDaniela Cerezo-Wallis
Daniela Cerezo-Wallis
LNLai Guan Ng
Lai Guan Ng
Neutrophils are increasingly recognized as key players in the tumor immune response and are associated with poor clinical outcomes. Despite recent advances characterizing the diversity of neutrophil states in cancer, common trajectories and mechanisms governing the ontogeny and relationship between these neutrophil states remain undefined. Here, we demonstrate that immature and mature neutrophils that enter tumors undergo irreversible epigenetic, transcriptional, and proteomic modifications to converge into a distinct, terminally differentiated dcTRAIL-R1 + state. Reprogrammed dcTRAIL-R1 + neutrophils predominantly localize to a glycolytic and hypoxic niche at the tumor core and exert pro-angiogenic function that favors tumor growth. We found similar trajectories in neutrophils across multiple tumor types and in humans, suggesting that targeting this program may provide a means of enhancing certain cancer immunotherapies.

3 March 2021 in Nature
Verified
Journal Article
Closed access
PDF file
NWNingbo Wu
Ningbo Wu
HSHongxiang Sun
Hongxiang Sun
XZXiaoyun Zhao
Xiaoyun Zhao
YZYao Zhang
Yao Zhang
JTJianmei Tan
Jianmei Tan
BSBing Su
Bing Su

26 July 2024 in Science Immunology
Verified
Journal Article
Closed access
GDGarett Dunsmore
Garett Dunsmore
WGWei Guo
Wei Guo
ZLZiyi Li
Ziyi Li
DBDavid Alejandro Bejarano
David Alejandro Bejarano
RPRhea Pai
Rhea Pai
FGFlorent Ginhoux
Florent Ginhoux
Tumor-associated macrophages (TAMs) are a heterogeneous population of cells whose phenotypes and functions are shaped by factors that are incompletely understood. Herein, we asked when and where TAMs arise from blood monocytes and how they evolve during tumor development. We initiated pancreatic ductal adenocarcinoma (PDAC) in inducible monocyte fate-mapping mice and combined single-cell transcriptomics and high-dimensional flow cytometry to profile the monocyte-to-TAM transition. We revealed that monocytes differentiate first into a transient intermediate population of TAMs that generates two longer-lived lineages of terminally differentiated TAMs with distinct gene expression profiles, phenotypes, and intratumoral localization. Transcriptome datasets and tumor samples from patients with PDAC evidenced parallel TAM populations in humans and their prognostic associations. These insights will support the design of new therapeutic strategies targeting TAMs in PDAC.

3 December 2025 in Nature
Verified
Journal Article
Open access
PDF file
DCDaniela Cerezo-Wallis
Daniela Cerezo-Wallis
ARAndrea Rubio-Ponce
Andrea Rubio-Ponce
MRMathis Richter
Mathis Richter
EPEmanuele Pitino
Emanuele Pitino
IKImmanuel Kwok
Immanuel Kwok
IBIván Ballesteros
Iván Ballesteros
Neutrophils exhibit remarkable phenotypic and functional diversity across tissues and diseases1,2, yet the lack of understanding of how this immune compartment is globally organized challenges translation to the clinic. Here we performed single-cell transcriptional profiling of neutrophils spanning 47 anatomical, physiological and pathological scenarios to generate an integrated map of the global neutrophil compartment in mice, which we refer to as NeuMap. NeuMap integrates and expands existing models3,4 to generate fundamental new insights; it reveals that neutrophils organize in a finite number of functional hubs that distribute sequentially during maturation to then branch out into interferon-responsive and immunosuppressive states, as well as a functionally silent state that dominates in the healthy circulation. Computational modelling and timestamp analyses identify prototypical trajectories that connect these hubs, and reveal that the dynamics and preferred paths vary during health, inflammation and cancer. We show that TGFβ, IFNβ and GM-CSF push neutrophils along the different trajectories, and projection of chromatin accessibility sites onto NeuMap reveals that the transcription factor JUNB controls angiogenic and immunosuppressive states and promotes tissue revascularization. The architecture of NeuMap appears to be conserved across sex, environmental and genetic backgrounds, as well as in humans. Finally, we show that NeuMap enables inference of the pathophysiological state of the host by profiling blood neutrophils. Our study delineates the global architecture of the neutrophil compartment and establishes a framework for exploration and exploitation of neutrophil biology.

14 January 2025 in Immunity
Verified
Journal Article
Closed access
MNMelissa Ng
Melissa Ng
DCDaniela Cerezo-Wallis
Daniela Cerezo-Wallis
LNLai Guan Ng
Lai Guan Ng
AHAndres Hidalgo
Andres Hidalgo